BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 23449384)

  • 1. Respiratory bacterial infections in cystic fibrosis.
    Ciofu O; Hansen CR; Høiby N
    Curr Opin Pulm Med; 2013 May; 19(3):251-8. PubMed ID: 23449384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bacterial sinusitis can be a focus for initial lung colonisation and chronic lung infection in patients with cystic fibrosis.
    Aanæs K
    J Cyst Fibros; 2013 Sep; 12 Suppl 2():S1-20. PubMed ID: 24064077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathophysiology and management of pulmonary infections in cystic fibrosis.
    Gibson RL; Burns JL; Ramsey BW
    Am J Respir Crit Care Med; 2003 Oct; 168(8):918-51. PubMed ID: 14555458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Challenging and emerging pathogens in cystic fibrosis.
    de Vrankrijker AM; Wolfs TF; van der Ent CK
    Paediatr Respir Rev; 2010 Dec; 11(4):246-54. PubMed ID: 21109184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cystic fibrosis lung microbiome.
    Surette MG
    Ann Am Thorac Soc; 2014 Jan; 11 Suppl 1():S61-5. PubMed ID: 24437409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacteriology and treatment of infections in the upper and lower airways in patients with primary ciliary dyskinesia: adressing the paranasal sinuses.
    Alanin MC
    Dan Med J; 2017 May; 64(5):. PubMed ID: 28552099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of sinus surgery with intensive follow-up on pathogenic sinus bacteria in patients with cystic fibrosis.
    Aanaes K; von Buchwald C; Hjuler T; Skov M; Alanin M; Johansen HK
    Am J Rhinol Allergy; 2013 Jan; 27(1):e1-4. PubMed ID: 23406585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paranasal sinus pathogens in children with cystic fibrosis: do they relate to lower respiratory tract pathogens and is eradication successful?
    Wilson P; Lambert C; Carr SB; Pao C
    J Cyst Fibros; 2014 Jul; 13(4):449-54. PubMed ID: 24713592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Current microbiological data on lower respiratory tract infection in cystic fibrosis. Part I: Isolated microorganisms and their clinical significance].
    Coman G; Petraru E; Dahorea C; Anton DT
    Rev Med Chir Soc Med Nat Iasi; 2012; 116(2):580-7. PubMed ID: 23077957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolution and diversification of Pseudomonas aeruginosa in the paranasal sinuses of cystic fibrosis children have implications for chronic lung infection.
    Hansen SK; Rau MH; Johansen HK; Ciofu O; Jelsbak L; Yang L; Folkesson A; Jarmer HØ; Aanæs K; von Buchwald C; Høiby N; Molin S
    ISME J; 2012 Jan; 6(1):31-45. PubMed ID: 21716309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Etiopathogenic and therapeutic aspects of chronic respiratory infection in cystic fibrosis].
    Caramia G; Gagliardini R; Rocchi AL; Palumbo P
    Minerva Pediatr; 1986 Jul; 38(13-14):569-78. PubMed ID: 3528799
    [No Abstract]   [Full Text] [Related]  

  • 12. Differential adaptation of microbial pathogens to airways of patients with cystic fibrosis and chronic obstructive pulmonary disease.
    Döring G; Parameswaran IG; Murphy TF
    FEMS Microbiol Rev; 2011 Jan; 35(1):124-46. PubMed ID: 20584083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between cystic fibrosis respiratory tract bacterial communities and age, genotype, antibiotics and Pseudomonas aeruginosa.
    Klepac-Ceraj V; Lemon KP; Martin TR; Allgaier M; Kembel SW; Knapp AA; Lory S; Brodie EL; Lynch SV; Bohannan BJ; Green JL; Maurer BA; Kolter R
    Environ Microbiol; 2010 May; 12(5):1293-303. PubMed ID: 20192960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The approach to Pseudomonas aeruginosa in cystic fibrosis.
    Bendiak GN; Ratjen F
    Semin Respir Crit Care Med; 2009 Oct; 30(5):587-95. PubMed ID: 19760546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The microbiome and emerging pathogens in cystic fibrosis and non-cystic fibrosis bronchiectasis.
    Green H; Jones AM
    Semin Respir Crit Care Med; 2015 Apr; 36(2):225-35. PubMed ID: 25826590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibiotic management of lung infections in cystic fibrosis. I. The microbiome, methicillin-resistant Staphylococcus aureus, gram-negative bacteria, and multiple infections.
    Chmiel JF; Aksamit TR; Chotirmall SH; Dasenbrook EC; Elborn JS; LiPuma JJ; Ranganathan SC; Waters VJ; Ratjen FA
    Ann Am Thorac Soc; 2014 Sep; 11(7):1120-9. PubMed ID: 25102221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulmonary infections in patients with cystic fibrosis.
    Rajan S; Saiman L
    Semin Respir Infect; 2002 Mar; 17(1):47-56. PubMed ID: 11891518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pulmonary infections in cystic fibrosis: pathogenesis and therapy].
    Götz M
    Monatsschr Kinderheilkd; 1985 Oct; 133(10):718-25. PubMed ID: 3934527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical effects of sinus surgery and adjuvant therapy in cystic fibrosis patients - can chronic lung infections be postponed?
    Aanaes K; Johansen HK; Skov M; Buchvald FF; Hjuler T; Pressler T; Hoiby N; Nielsen KG; von Buchwald C
    Rhinology; 2013 Sep; 51(3):222-30. PubMed ID: 23943728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Challenges with current inhaled treatments for chronic Pseudomonas aeruginosa infection in patients with cystic fibrosis.
    Greally P; Whitaker P; Peckham D
    Curr Med Res Opin; 2012 Jun; 28(6):1059-67. PubMed ID: 22401602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.